Mednax Inc (MD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Mednax Inc (MD) has a cash flow conversion efficiency ratio of -0.147x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-129.50 Million) by net assets ($878.58 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Mednax Inc to measure how many days the company can operate on defensive assets alone.
Mednax Inc - Cash Flow Conversion Efficiency Trend (1994–2025)
This chart illustrates how Mednax Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Mednax Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mednax Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Castrol India Limited
NSE:CASTROLIND
|
0.356x |
|
Xinjiang Machinery Research Inst
SHE:300159
|
0.010x |
|
Liberty Media Corporation Series A Liberty Formula One Common Stock
NASDAQ:FWONA
|
0.042x |
|
Far Eastern International Bank
TW:2845
|
-0.049x |
|
PSG Konsult Ltd
JSE:KST
|
0.164x |
|
Getty Realty Corporation
NYSE:GTY
|
0.030x |
|
Evergreen Aviation Tech Corp
TW:2645
|
0.059x |
|
Domain Holdings Australia Ltd
AU:DHG
|
0.049x |
Annual Cash Flow Conversion Efficiency for Mednax Inc (1994–2025)
The table below shows the annual cash flow conversion efficiency of Mednax Inc from 1994 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Mednax Inc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $865.85 Million | $271.09 Million | 0.313x | +15.94% |
| 2024-12-31 | $764.94 Million | $206.57 Million | 0.270x | +66.97% |
| 2023-12-31 | $849.06 Million | $137.32 Million | 0.162x | -13.62% |
| 2022-12-31 | $891.63 Million | $166.94 Million | 0.187x | +118.78% |
| 2021-12-31 | $896.69 Million | $76.74 Million | 0.086x | -68.73% |
| 2020-12-31 | $747.72 Million | $204.62 Million | 0.274x | +18.34% |
| 2019-12-31 | $1.50 Billion | $346.64 Million | 0.231x | +146.29% |
| 2018-12-31 | $3.09 Billion | $289.93 Million | 0.094x | -43.70% |
| 2017-12-31 | $3.07 Billion | $511.38 Million | 0.167x | +3.75% |
| 2016-12-31 | $2.76 Billion | $443.78 Million | 0.161x | +6.28% |
| 2015-12-31 | $2.44 Billion | $368.70 Million | 0.151x | -18.93% |
| 2014-12-31 | $2.27 Billion | $422.64 Million | 0.187x | +7.82% |
| 2013-12-31 | $2.34 Billion | $405.40 Million | 0.173x | +8.13% |
| 2012-12-31 | $2.04 Billion | $325.69 Million | 0.160x | +2.20% |
| 2011-12-31 | $1.73 Billion | $271.02 Million | 0.157x | -5.79% |
| 2010-12-31 | $1.45 Billion | $240.56 Million | 0.166x | -18.06% |
| 2009-12-31 | $1.19 Billion | $241.37 Million | 0.203x | +7.91% |
| 2008-12-31 | $965.14 Million | $181.39 Million | 0.188x | -4.39% |
| 2007-12-31 | $959.05 Million | $188.52 Million | 0.197x | -3.99% |
| 2006-12-31 | $865.80 Million | $177.27 Million | 0.205x | -12.79% |
| 2005-12-31 | $691.79 Million | $162.42 Million | 0.235x | +8.33% |
| 2004-12-31 | $571.03 Million | $123.75 Million | 0.217x | +5.09% |
| 2003-12-31 | $572.38 Million | $118.03 Million | 0.206x | +15.50% |
| 2002-12-31 | $548.00 Million | $97.84 Million | 0.179x | -5.36% |
| 2001-12-31 | $478.85 Million | $90.34 Million | 0.189x | +26.24% |
| 2000-12-31 | $241.90 Million | $36.15 Million | 0.149x | +42.53% |
| 1999-12-31 | $228.90 Million | $24.00 Million | 0.105x | -35.66% |
| 1998-12-31 | $207.40 Million | $33.80 Million | 0.163x | -8.01% |
| 1997-12-31 | $163.70 Million | $29.00 Million | 0.177x | +63.15% |
| 1996-12-31 | $136.30 Million | $14.80 Million | 0.109x | +15.58% |
| 1995-12-31 | $62.80 Million | $5.90 Million | 0.094x | -71.99% |
| 1994-12-31 | $16.10 Million | $5.40 Million | 0.335x | -- |
About Mednax Inc
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners,… Read more